Ka. Kesler et al., Primary mediastinal nonseminomatous germ cell tumors: The influence of postchemotherapy pathology on long-term survival after surgery, J THOR SURG, 118(4), 1999, pp. 692-700
Citations number
15
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objectives: The treatment of nonseminomatous germ tell tumors with cisplati
n-based chemotherapy followed by aggressive surgical resection of residual
disease is one of the most successful models for multimodality cancer thera
py. We reviewed the case histories of 91 patients treated at our institutio
n from 1981 to 1998 with primary mediastinal nonseminomatous germ cell tumo
rs to evaluate variables that may influence survival after surgery Methods:
Twelve of the 91 patients did not undergo postchemotherapy resection becau
se of progressive disease. Seventy-nine of them underwent 82 thoracic surgi
cal procedures and are the basis of this review The majority (71/75) had el
evated serum tumor markers, 75% (n = 50) of which returned to normal levels
after first- or second-line chemotherapy. Results: There were 3 operative
deaths and I late death, attributed to pulmonary complications. Twenty-four
patients died of recurrent disease and 3 of leukemia, for an overall survi
val of 61% after an average follow-up of 48 months. The pathologic findings
of complete tumor necrosis (n = 19) and benign teratoma (n = 28) in the su
rgical specimen predicted excellent and good long-term survival, respective
ly, which was statistically better than that of patients having persistent
nonseminomatous germ cell turners (n = 24) or carcinomatous/sarcomatous deg
eneration (n = 8), Conclusions: primary nonseminomatous germ cell tumors of
the mediastinum can be cured with a multimodality therapy, particularly in
the subset of patients with postchemotherapy pathologic findings of tumor
necrosis and teratoma, Survival is poor but possible in patients with unfav
orable pathologic findings after chemotherapy, currently justifying an aggr
essive surgical approach in patients with otherwise operable disease.